Contest Trader

Don't miss the chance to cash-in prizes totaling

$10.000
Register here for the Ultimate demo trading competition

Optimism drove the markets higher - Tuesday Review, November 10

Optimism drove the markets higher - Tuesday Review, November 10

While some markets focused on the earnings season, others praised Pfizer’s vaccine

The US

The vaccine’s effect on the markets started to wear off. Also, the new devices from Microsoft and Apple didn’t stir things up. The USA30 gained 0.9%, while USA500 lost 0.11%. TECH100 fell 1.37%.

Gold went up 1.2%, trading at $1,876.40 per ounce.

Oil climbed 0.9% at $40.64 per barrel. Brent oil closed 1% higher at $42.84.

Asia and Australia

Despite the disappointing figures for last month’s Consumer Price Index (CPI) and Producer Price Index (PPI), the benchmarks closed in the green.

HongKong45 rose 0.90%.

Japan225 went up 0.66%after prime-minister Suga instructed the cabinet to put together a new stimulus package to help the country’s battered economy.

Down under, Australia200 traded 0.59% higher.

Europe

The markets closed predominantly higher, some of them keeping the optimism induced by Pfizer’s COVID-19 vaccine announcement. Germany30 closed 0.4% lower. France40 and UK100 went up 0.7% and 0.4%, respectively.

EUR/USD traded at 1.1835 after gaining 0.2%.

Sources: investing.com

This information prepared by za.capex.com is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.

This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation or the particular needs of any recipient.

You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.

This information may not be published, circulated, reproduced or distributed in whole or in part to any other person without the Company’s prior written consent. Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of za.capex.com